Company / Tangible Book Value per Share
Crinetics Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$10.38
FY2025
5-year range
$5.87 / $14.26
FY2021-FY2025
Trend
-27.2%
vs FY2024
Sector context
#48 of 209
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s tangible book value per share of $10.38 is higher than 77% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-624.33 in FY2019 to $14.26 in FY2024.
Based on SEC 10-K filings.
10.38 in FY2025 with a 5-year CAGR of +9.5%. Top quartile in the Health Care sector.
Improved from $9.28 to $10.38 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +20.9%
- 5-Year CAGR
- +9.5%
- 10-Year CAGR
- -
Sector benchmark
-88.9% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 27.2% year-over-year.
- Ranks #48 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.38 | -27.2% |
| FY2024 | $14.26 | +53.6% |
| FY2023 | $9.28 | +58.1% |
| FY2022 | $5.87 | -15.8% |
| FY2021 | $6.97 | +5.6% |
| FY2020 | $6.60 | +101.1% |
| FY2019 | -$624.33 | -15493.9% |
| FY2018 | -$4.00 | +63.5% |
| FY2017 | -$10.96 | -78.6% |
| FY2016 | -$6.14 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026